Use: Labeled indications
- INDICATIONS AND USAGE Intravenous solutions containing sodium chloride are indicated for parenteral replenishment of fluid and sodium chloride as required by the clinical condition of the patient.
Full indications and usage US FDA label
INDICATIONS AND USAGE Intravenous solutions containing sodium chloride are indicated for parenteral replenishment of fluid and sodium chloride as required by the clinical condition of the patient.
Contraindications
CONTRAINDICATIONS None known.
US FDA labelDosing: Adult
Dosage and administration (US label) US FDA label
DOSE AND ADMINISTRATION The dose is dependent upon the age, weight and clinical condition of the patient. Additives may be incompatible. Consult with pharmacist, if available. When introducing additives, use aseptic technique, mix thoroughly and do not store. Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. (See PRECAUTIONS.)
Dosing: Altered kidney function
No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.
Kidney-specific guidance from renalcarematters.com: in preparation.
Dosage forms
Philippines
- Solution for intravenous infusion: 9 mg/mL, 30 mg/mL, 900 mg/100 mL
- Solution for iv infusion: 9 mg/mL, 900 mg/100 mL
- Solution for injection: 2.5 mEq/mL, 9 mg/mL
- Solution for i.v. infusion: 9 mg/mL, 900 mg per 100 mL, 900 mg/100 mL
- Nasal spray: 6.5 mg/mL
- Solution for irrigation: 9 mg/mL
- Ophthalmic solution: 50 mg/mL
- Solution for intravenous: 900 mg/100 mL
- Solution for nebulization: 5 mg/mL, 6.5 mg/mL
- ) normal saline solution: 900 mg/100 mL
and 12 more forms; see the products table.
Registered products in the Philippines
91 products registered with the Food and Drug Administration (FDA) Philippines list Sodium chloride as the generic name (including products registered under a variant spelling). Registration status changes; confirm a product's current status on the FDA portal before relying on it.
Also registered under: 0.9% Sodium Chloride S (1 product). Products registered under these spellings are included in the table and marked.
All registered products91
| Package insert | |||||||
|---|---|---|---|---|---|---|---|
0.9% NaCl-Sapher0.9% Sodium Chloride | 9 mg/mL (0.9% w/v) Solution For InjectionLDPE vial enclosed with grey bromobutyl rubber stopper x 10 mL, 20 mL & 50 mL (Box of 20's) | Rx | Althea Pharma Pvt. Ltd.India | Nelpa Lifesciences, Inc.Trader: Sapphire Lifesciences Pvt. Ltd. | DRP-12416 | Aug 4, 2027 | |
0.9% Sodchlorsaph0.9% Sodium Chloride | 900 mg/100 mL (0.9% w/v) Solution for IV InfusionLDPE Bottle x 500 mL and 1 L with white dust cap | Rx | Althea Pharma Pvt. Ltd.India | Nelpa Lifesciences, Inc.Trader: Sapphire Lifesciences Pvt. Ltd. | DRP-14865 | Jan 25, 2029 | |
A.N.B.0.9% Sodium Chloride | 900 mg/100 mL Solution for Intravenous Infusion (IV)Polypropylene (PP) Plastic Bottle X (Net Content: 50 mL and 100 mL), 500 mL (Net Content: 250 mL and 500 mL), and 1 L with pull-off cap (Polypropylene plastic and butyl rubber disc) | Rx | A.N.B. Laboratories Company LimitedThailand | Optimum Trading | DR-XY35226 | Sep 4, 2028 | |
A.N.B. Sodium Chloride Normal Saline SolutionSodium Chloride | 0.9% (900 mg/100mL) Normal Saline SolutionPolypropylene (PP) Plastic Bottle x 30mL, 50 mL, 100 mL, 500 mL and, 1000 mL Bottle of 1's | Rx | A.N.B. Laboratories Co. Ltd.Thailand | Optimum Trading | DR-XY35227 | Dec 15, 2030 | |
Axaline 3.0%Sodium Chloride | 30mg/mL (3% w/v) Solution for Intravenous Infusion250 mL LDPE bottle (Box of l's) | Rx | Axa Parenterals LimitedIndia | S.M.H.P. Marketing & Consultancy | DR-XY48414 | Oct 7, 2027 | |
Breathe EzySodium Chloride | 0.65% Buffered Solution Nasal Drops60 mL LDPE Squeezable Natural Bottle with Cap (Box of 1's) | OTC | Lloyd Laboratories, Inc.Philippines | TGP Pharma Inc.Trader: D.B. Manix International, Inc. | DR-XY41749 | Feb 25, 2028 | |
Breathe EzySodium Chloride | 0.65% Buffered Solution Nasal Spray60 mL and 20 mL White HDPE Pump Bottle (Box of 1's) | OTC | Lloyd Laboratories, Inc.Philippines | TGP Pharma Inc.Trader: D.B. Manix International, Inc. | DR-XY41746 | Feb 25, 2028 | |
ClirnazeSodium Chloride | 6.5 mg/mL Nasal SprayWhite HDPE Nasal Spray Bottle x 30 mL (Box of 1's) | OTC | Lifesquare Laboratories Inc.Philippines | Novomed Inc. | DRP-8484-02 | Oct 17, 2029 | |
Dexros 0.9%0.9% Sodium Chloride | 900mg/100mL (0.9% w/v) Solution for IV InfusionLDPE Plastic Bottle x 100mL, 500mL and 1L | Rx | Aculife Healthcare Private LimitedIndia | Biocare Lifesciences, Inc.Importer: Blue Global (FZE) | DRP-15142-01 | May 13, 2029 | |
HypersaltSodium Chloride | 50 mg/mL (5% w/v) Ophthalmic Solution10 mL HDPE plastic bottle with pilfer-guard eyedropper (Box of 1's) | Rx | EL. Laboratories, Inc.Philippines | Trader: Vista Pharma, Inc. | DR-XY28903 | Apr 16, 2027 | |
ISO - Quinosil0.9% Sodium Chloride | 9mg/mL (0.9%) Solution for Intravenous InfusionUSP Type II Clear and Colorless glass vial with bromobutyl rubber stopper and aluminum crimp seal with gray plastic cap x 50mL, 100mL, 500mL and 1L (Box of 6's) | Rx | Royale Life Pharma Inc.Philippines | Quinosil Laboratory Inc. | DRP-13263-01 | Jan 19, 2028 | |
MuconaseSodium Chloride | 0.65% Saline Solution for Nasal SprayPlastic Bottle X 30mL & 60 mL Not Applicable | Rx | Hizon Laboratories, Inc.Philippines | Trader: Pharma Nutria N.A., Inc. | DR-XY29187 | Nov 28, 2030 | |
NaCl-Saph0.9 % Sodium Chloride | 9 mg/mL (0.9%w/v) Solution for Injection (IV Infusion)White LDPE Bottle Sealed with Dust Cap x 500 mL and 1L | Rx | Jedux Parenteral Private LimitedIndia | Nelpa Lifesciences, Inc.Trader: Sapphire Lifesciences Pvt. Ltd. | DRP-12667 | Sep 21, 2027 | |
NACLO0.9% Sodium Chloride | 900 mg/100 mL (0.9% w/v) Solution for Intravenous InfusionLDPE Bottle in polypouch film, with dust cap x 100 mL (Box of 1's) and 500 mL (Box of 25's) | Rx | Eurolife Healthcare Pvt. Ltd.India | Aglobal Care, Inc. | DRP-13690 | Apr 13, 2028 | |
Nacsave0.9% Sodium Chloride | 900 mg/ 100 mL (0.9% w/v) Solution for Intravenous InfusionLDPE Bottle x 500 mL and 1 L with white dust cap | Rx | Shijiazhuang No. 4 Pharmaceutical Co., Ltd.China | Savelink Pharma And Trading Co.Importer: Aglobal Care, Inc. | DRP-14798-03 | Jan 9, 2029 | |
Nacvire0.9% Sodium Chloride | 900 mg/100 mL (0.9% w/v) Solution for Intravenous InfusionLDPE Bottle x 1L with white dust cap | Rx | Shijiazhuang No. 4 Pharmaceutical Co., Ltd.China | Solvire Life IncorporatedImporter: Aglobal Care, Inc. | DRP-14798-04 | Jan 9, 2029 | |
NasalinSodium Chloride | 6.5 mg/ mL Nasal SprayWhite HDPE Nasal Spray Bottle x 30 mL Box of 1's | OTC | LIFESQUARE LABORATORIES INC.Philippines | KORN C PHILIPPINES INC. | DRP-8484-04 | Oct 17, 2029 | |
Nasaph-ClSodium Chloride | 6.5 mg/mL (0.65% w/v) Nasal DropsWhite LDPE Plastic Bottle with Plastic Cap 30ml and 60ml (Box of 1's) | OTC | Kilitch Drugs (India) LimitedIndia | Nelpa Lifesciences Inc.Trader: Sapphire Lifesciences Pvt. Ltd. | DRP-14630 | Nov 8, 2028 | |
Nasaph-ClSodium Chloride | 6.5 mg/mL (0.65% w/v) Nasal SprayWhite LDPE Plastic Bottle with Plastic Cap 30mL and 60mL (Box of 1's) | OTC | Kilitch Drugs (India) LimitedIndia | Nelpa Lifesciences, Inc.Trader: Sapphire Lifesciences Pvt. Ltd. | DRP-14631 | Nov 8, 2028 | |
NasoClearSodium Chloride | 6.5 mg/mL (0.65%) Saline Solution Nasal SprayWhite Plastic Bottle x 30 mL with Plastic Cap (Box of 1's) | OTC | Hizon Laboratories, Inc.Philippines | Trader: UNILAB, Inc. | DRP-1690 | Nov 4, 2029 | |
NasofastSodium Chloride | 6.50 mg (0.65% w/v) per mL Nasal Solution (Spray)White Plastic Spray Bottle with Plug, Pipe and Cap x 20 mL (Box of 1's) | OTC | Meridian Enterprises Pvt. Ltd.India | AMB HK Enterprises Inc. | DRP-15847 | Sep 23, 2029 | |
NasoliefSodium Chloride | .5 mg/mL (0.65% w/v) Solution for NebulizationWhite polypropylene ampoule x 2.5 mL (Box of 10’s and 50’s) | OTC | Hebei Tiancheng Pharmaceutical Co., LtdChina | Importer: AMB HK Enterprises Inc. | DRP-19138 | Nov 10, 2031 | |
NasorinseSodium Chloride | 6.5 mg/mL (0.65%) Nasal SprayWhite Plastic Bottle x 45 mL with Plastic Cap with Spray | OTC | Hizon Laboratories, Inc.Philippines | Trader: Willore Pharma Corporation | DR-XY46517 | Feb 15, 2029 | |
NIR-NS0.9% Sodium Chloride | (see reverse for formulation) Solution for I.V. InfusionLDPE Bottle x 100 mL; LDPE Bottle x 500 mL; LDPE Bottle x 1 L | Rx | Aculife Healthcare Pvt. Ltd.India | HLN Phil. Trading Inc. | DRP-12928 | Apr 23, 2028 | |
None0.9% Sodium Chloride | 0.9% (w/v) Solution for IrrigationLDPE Twist off Plastic Bottle x 1 L | Rx | Aculife Healthcare Pvt. Ltd.India | PFC Drug Distributors Company Ltd. | DRP-12927 | Jun 23, 2031 | |
NoneSodium Chloride | 0.9% Solution for Inhalation2.5 mL LDPE Plastic Ampoule (Box of 50's) | Rx | Euro-Med Laboratories Phil., Inc.Philippines | — | DR-XY28206 | Sep 3, 2028 | |
NoneSodium Chloride | 0.9% w/v Solution For IV InfusionType glass 1 flint glass vial 50mL; Type 1 Flint glass vial with rubber stopper & aluminum seal 5 | Rx | Best Drug Industries, Inc.Philippines | — | DRP-924 | May 29, 2030 | |
NoneSodium Chloride | 1 g TabletWide Mouthed Amber Glass Bottle x 100's | Rx | Amherst Laboratories, Inc.Philippines | Trader: Philusa Corporation | DR-XY7267 | Sep 29, 2028 | |
NoneSodium Chloride | 2.5 mEq/mL Parenteral SolutionClear Plastic Vial x 20 mL | Rx | Euro-Med Laboratories Phil., Inc.Philippines | — | DR-XY19930 | May 16, 2027 | |
NoneSodium Chloride | 2.5 mEq/mL Solution for Injection (IV Infusion)Glass clear vial with gray rubber stopper and plain aluminum seal x 20 mL (Box of 10's) | Rx | E.L. Laboratories, Inc.Philippines | Trader: Elin Pharmaceuticals, Inc. | DR-XY19962 | May 23, 2030 | |
NoneSodium Chloride | 50 mg/ mL (5% w/v) Ophthalmic Solution10 mL white LDPE plastic bottle with white LDPE nozzle and white HDPE cap (Box of 1's) | Rx | EL LABORATORIES, INC.Philippines | Trader: SENSOMED PHILS., INC. | DR-XY31067 | Feb 6, 2029 | |
NoneSodium chloride | 9 mg/mL (0.9 %) Solution for Intravenous InfusionPolyolefine (Freeflex) Bag x 250 mL; Polyolefine (Freeflex) Bag x 500 mL; Polyolefine (Freeflex) Bag x 1 L | Rx | Fresenius Kabi Deutschland GmbHGermany | Fresenius Kabi Philippines, Inc. | DR-XY42781 | Oct 14, 2028 | |
NoneSodium Chloride | 9 mg/mL (0.9% w/v) Solution for Injection (I.V.)LDPE Ampoule x 10mL (Box of 6's) | Rx | Zhejiang Tianrui Pharmaceutical Co., Ltd.China | Global Pharmatrade | DR-XY41900 | Feb 9, 2031 | |
None0.9% Sodium Chloride | 9 mg/mL (0.9% w/v) Solution for Injection (I.V.)LDPE Plastic Ampoule x 10mL (net content) (Box of 50's) | Rx | Aculife Healthcare Pvt. Ltd.India | PFC Drug Distributors Company Ltd. | DRP-12434 | Jul 8, 2029 | |
none0.9% Sodium Chloride | 9 mg/mL (0.9% w/v) Solution for Intravenous InfusionPolypropylene (PP) infusion bottle with PP infusion compound cap x 500 mL. | Rx | Chimin Health Management Co., Ltd.China | Hexagon PharmaceuticalsTrader: Nanjing Pharmacare Co., Ltd. | DRP-13899 | May 28, 2028 | |
NoneSodium Chloride | 9 mg/mL (0.9% w/v) Solution for IV Infusion100 mL FFS Bottle (PE) x 100 mL -; 100 mL FFS Bottle (PE) x 50 mL - | Rx | Jinling Pharmaceutical Co., Ltd. Zhejiang Tianfeng Pharmaceutical FactoryP.R. China | Global Pharmatrade | DR-XY42572 | Jan 13, 2032 | |
NoneSodium Chloride | 9 mg/mL (0.9%) SolutionLow Density Polyethylene (LDPE) Bottle in: 2 mL, 3 mL, 5 mL and 10 mL ampoule (Box of 50's); 20 mL ampoule (Box of 20's, 50's & 100's); 50 mL LDPE Vial without rubber stopper (Box of 20's) | Rx | Euro-Med Laboratories Phil., Inc.Philippines | — | DR-XY24884 | Mar 2, 2029 | |
None0.9% Sodium Chloride | 900 mg/100 mL (0.9% Sodium Chloride) Solution for IV InfusionLDPE Plastic Bottle x 100 mL, 500 mL, 1 L | Rx | Aculife Healthcare Private LimitedIndia | Delex Pharma International, Inc.Importer: Blue Global (FZE) | DRP-15142-02 | May 13, 2029 | |
None0.9% Sodium Chloride | 900 mg/100 mL Solution for Intravenous InfusionPolyethylene Bottle (Ecoflac) x 100 mL, 500 mL and 1000 mL | Rx | B. Braun Medical Industries Sdn. Bhd.Malaysia | Importer: B. Braun Medical Supplies, Inc. | DR-XY46124 | Oct 24, 2027 | |
None0.9% Sodium Chloride | 900 mg/100 mL Solution for IV InfusionUSP Type II Glass Bottle with rubber stopper and overseal x 500 mL; 1000 mL | Rx | Euro-Med Laboratories Phil., Inc.Philippines | — | DR-4660 | Nov 4, 2037 | |
None0.9% Sodium Chloride | 900 mg/100 mL Solution for IV InfusionPolypropylene Bag with injection and infusion ports x 100 mL, 500 mL and 1000 mL | Rx | Euro-Med Laboratories Phil., Inc.Philippines | — | DR-XY40137 | Sep 23, 2037 | |
None0.9% Sodium Chloride | 900mg/100mL (0.9% w/v) Solution for IntravenousLow Density Polyethylene (LDPE) Bottle x 1 Liter with white dust cap (Box of 1's) | Rx | Shijiazhuang No. 4 Pharmaceutical Co., Ltd.China | Rifemedica CorporationImporter: AGlobal Care, Inc. | DRP-14798-02 | Jan 9, 2029 | |
none0.9% Sodium Chloride | 9mg/mL (0.9% w/v) Solution for Intravenous InfusionPolypropylene (PP) infusion bottle with PP infusion compound cap x 1L | Rx | Chimin Health Management Co., Ltd.China | Hexagon PharmaceuticalsTrader: Nanjing Pharmacare Co., Ltd. | DRP-13900 | May 15, 2028 | |
None0.9% Sodium Chloride | Solution for I.V. InfusionLDPE Plastic Container x 500 mL and 1000 mL | Rx | Euro-Med Laboratories Phil., Inc.Philippines | — | DR-XY13332 | Jun 25, 2027 | |
None0.9% Sodium Chloride | Solution for InjectionLow Density Polyethylene Vial with Rubber Stopper (20 mL & 50 mL) | Rx | Euro-Med Laboratories Phil., Inc.Philippines | — | DR-XY18875 | Sep 29, 2037 | |
None0.9% Sodium Chloride | Solution for Intravenous Infusion50 mL, 100 mL, and 1 L Non-PVC Multi-layer co-extrusion film infusion bag | Rx | Cisen Pharmaceutical Co., Ltd.China | Endure Medical Inc. | DR-XY45355 | Jan 18, 2028 | |
None0.9% Sodium Chloride | Solution For IrrigationPolypropylene Infusion Bottle of 1000 mL | Rx | Shanxi Nuocheng Pharmaceutical Co., Ltd.China | Endure Medical Inc. | DR-XY40976 | Jun 21, 2027 | |
None0.9% Sodium Chloride | Solution for IV Infusion100 mL, 500 mL and 1000 mL Non-PVC Bag (Unibag) | Rx | OTSUKA PHARMACEUTICAL INDIA PRIVATE LIMITEDIndia | OTSUKA (PHILIPPINES) PHARMACEUTICAL, INC. | DR-XY36772 | Dec 5, 2029 | |
NS0.9% Sodium Chloride | 9 mg/mL (0.9% w/v) Solution for Intravenous Infusion1L LDPE Bottle with Euro head cap | Rx | AXA Parenterals LimitedIndia | S.M.H.P Marketing & Consultancy | DRP-12869 | Oct 18, 2027 | |
NS0.9% Sodium Chloride | 9 mg/mL (900 mg/100 mL) Solution for IV InfusionLDPE transparent bottle x 100 mL (Box of 1's) | Rx | Captab Biotec Unit IIIndia | Finstad Inc. | DRP-18468 | Jul 23, 2031 | |
9mg/mL (0.9% w/v) Solution For I.V. InfusionLDPE bottle with head cap composed of bromobutyl rubber disc and ring pull-type plastic seal x 500 mL and 1 L | Rx | Abaris Healthcare Pvt. Ltd.India | One Dexcel Pharma, Inc. | DRP-12356 | Jul 22, 2027 | ||
PartnersSodium Chloride | 900 mg/100 mL (0.9% w/v) Solution for IntravenousClear Colorless Polypropylene (PP) bottle sealed with Bromobutyl Rubber stopper with Colorless Plastic Protective Flip-off (holder) Cap x 50 mL, 100 mL, 250 mL, 500 mL and 1 L | Rx | Shijiazhuang No. 4 Pharmaceutical Co., LtdChina | Champion Biotech and Pharma Corporation | DRP-7236 | Sep 15, 2030 | |
Polifleks0.9% Sodium chloride | 9 mg/mL (0.9% w/v) Solution for I.V. InfusionPolypropylene (PP) and PVC bag, Injection port, SFC port and SFC cap x 500 mL (net content) | Rx | Polifarma Ilac, San Vc Tic. A.S.Turkey | Endure Medical, Inc. | DRP-13247 | Jan 18, 2028 | |
Roysal0.9% Sodium Chloride | 9 mg/mL (0.9%) Solution for Intravenous Infusion.USP Type II Clear and colorless glass vial with bromobutyl rubber stopper and aluminum crimp seal with gray plastic cap x 50 mL,100 mL, and 500 mL (Box of 6's) | Rx | Royale Life Pharma Inc.Philippines | — | DRP-13263 | Jan 19, 2028 | |
Sabidex PNSS0.9% Sodium Chloride | 900 mg/100 mL (0.9% w/v) Solution for Intravenous InfusionLDPE Bottle x 1 L with white dust cap | Rx | Shijiazhuang No. 4 Pharmaceutical., LtdChina | Sabijon DistributionImporter: Aglobal Care, Inc. | DRP-14798-01 | Jan 9, 2029 | |
SalacynSodium Chloride | 50 mg/mL (5% w/v) Sterile Opthalmic Solution (Drops)White LDPE Dropper-Tip Bottle x 10 mL (Box of 1’s) | Rx | Laboratorios Ashford LDA.China | Marrion Pharma, Inc. | DRP-6059 | Jan 5, 2030 | |
SalacynSodium Chloride | 9 mg/mL (0.9% w/v) Sterile Ophthalmic Solution DropsLDPE White Bottle and HDPE White Cap x 10 mL (Box of 1’s) | Rx | Laboratorios Ashford LDAChina | Marrion Pharma Inc. | DR-XY35243 | Dec 19, 2030 | |
SalinaseSodium Chloride | 0.65% Buffered Solutions30 mL printed white LDPE plastic bottle with tubing and white plastic cap (Box of 1's) | OTC | EL Laboratories, Inc.Philippines | Trader: Pediapharma, Inc. | DR-XY20973 | Nov 22, 2031 | |
SalinaseSodium Chloride | 6.5 mg/mL (0.65% w/v) Solution for NebulizationWhite HDPE Nebulizer Bottle with White HDPE plastic cap x 2.5 mL Box of 12's | OTC | EL Laboratories, Inc.Philippines | Trader: Pediapharma, Inc. | DR-XY30142 | Oct 15, 2029 | |
SalinateSodium Chloride | 2.5 mEq/mL Solution for Injection (IV Infusion)USP Type I clear and colorless glass vial x 20 mL (net content) with grey bromobutyl rubber stopper, aluminum seal, and grey plastic cap (Box of 15's) | Rx | Royale Life Pharma Inc.Philippines | — | DRP-17009 | Sep 5, 2030 | |
Salnor0.9% Sodium Chloride | 9 mg/mL (0.9% w/v) Solution for IV InfusionLight Density Polyethylene (LDPE) Bottle with nipple head and orange cap x 500 mL and 1 L | Rx | OTSUKA PHARMACEUTICAL INDIA PRIVATE LIMITEDIndia | OTSUKA (PHILIPPINES) PHARMACEUTICAL, INC. | DR-XY36670 | Sep 17, 2029 | |
SITI-PNSS0.9% Sodium chloride | 9 mg/mL (0.9% w/v) Solution for I.V. InfusionPolypropylene (PP) Plastic Bottle in 1L (net content) | Rx | Shijiazhuang No. 4 Pharmaceutical Co., Ltd.China | Sahar International Trading, Inc. | DR-XY46733 | Sep 25, 2029 | |
SITI-PNSS0.9% Sodium chloride | 9 mg/mL (0.9% w/v) Solution for IrrigationPolypropylene plastic bottle in 1 L (net content) | Rx | Shijiazhuang No.4 Pharmaceutical Co., Ltd.China | Sahar International Trading, Inc. | DR-XY46732 | Sep 25, 2029 | |
SonaphilSodium Chloride | 9 mg/mL (0.9% w/v) Solution for I.V. InfusionPolypropylene bottle with dust cap x 50 mL, 100 mL, 500 mL, and 1000 mL | Rx | Hebei Tiancheng Pharmaceutical Co., Ltd.China | AMB HK Enterprises Inc.Importer: PhilRx Pharma Inc. | DRP-12786-01 | Oct 7, 2027 | |
SqraxSodium Chloride | 6.5 mg/mL Nasal SprayWhite HDPE Nasal Spray Bottle x 30 mL (Box of 1’s) | OTC | LIFESQUARE LABORATORIES INC.Philippines | ALMAN PHARMACEUTICALS, INC. | DRP-8484-01 | Oct 17, 2029 | |
StuffiNOseSodium Chloride | 6.5 mg/mL Nasal SprayWhite HDPE Nasal Spray Bottle x 30mL (Box of 1's) | OTC | LifeSquare Laboratories, Inc.Philippines | — | DRP-8484 | Oct 17, 2029 | |
Synuz CleanseSodium Chloride | 9 mg/mL (0.9%) Granules for Nasal IrrigationPolypanium Foil (Paper/Polyethylene/Aluminum) Sachet (Box of 10 Sachets); 1 Bottle Applicator + 6 Sachets (Box of 1's); 1 Bottle Applicator + 10 Sachets (Box of 1's) | Rx | Sydenham Laboratories, Inc.Cavite | Sydenham Laboratories, Inc. | DR-XY45614 | Sep 28, 2031 | |
Unbranded0.9% Sodium Chloride | (see reverse) Solution for Intravenous Infusion5-Layer Co-extrusion Soft Bag with Butyl Rubber Stopper and Flip-Off Seal 500 mL and 1000 mL | Rx | Shanxi Nuocheng Pharmaceutical Co., Ltd.China | Endure Medical, Inc. | DR-XY39766 | Jul 14, 2031 | |
UnbrandedSodium Chloride | 0. 9% Solution for IV Infusion5 mL, 500 mL (Oval), I L (Flat), LOPE Plastic Bottle with Eurohead Not Applicable | Rx | Albert David LimitedIndia | I.E. Medica Inc.Importer: Medethix, Inc. | DRP-5281-01 | Dec 8, 2031 | |
UnbrandedSodium Chloride | 0.9% Solution for Infusion (I.V.) | Rx | MARION LABORATORIES (PVT) LTD. | SAHAR INTERNATIONAL TRADING INC. | DR-XY40311 | Nov 17, 2026Past listed date | |
UnbrandedSodium Chloride | 0.9% Solution for IrrigationLow Density Polyethylene Vial with twist-off closure; Low Density Polyethylene Bottle with twist-off closure 30 mL and 1000 mL | Rx | Euro-Med Laboratories Phil., Inc.Philippines | — | DRP-3153 | Oct 20, 2037 | |
Unbranded0.9% Sodium Chloride | 0.9% Solution for IV Infusion5 mL, 500 mL (oval), 1 L (flat) LDPE Plastic Bottle with Eurohead Not Applicable | Rx | Albert David LimitedIndia | Medethix, Inc. | DRP-5281 | Apr 18, 2030 | |
UnbrandedSodium Chloride | 0.9% w/v Solution for Intravenous InjectionPlastic Ampoule x 10 mL Box of 50's | Rx | OTSUKA PHARMACEUTICAL INDIA PRIVATE LIMITEDIndia | OTSUKA (PHILIPPINES) PHARMACEUTICAL, INC. | DR-XY43332 | Apr 1, 2029 | |
Unbranded0.9% SODIUM CHLORIDE | 9 MG / ML SOLUTION FOR INJECTION (I.V.) | Rx | HIZON LABORATORIES, INC. | — | DR-XY4224 | Mar 21, 2027 | |
UnbrandedSodium Chloride | 900 mg / 100 mL (0.9% w/v) Solution for I.V. InfusionRectangular LDPE Plastic Bottle x 1L | Rx | Euro-med laboratories Phil. Inc.Philippines | Trader: B Braun Avitum Phils. Inc. | DR-XY36143 | Jul 3, 2029 | |
Unbranded0.9% Sodium Chloride | 900 mg / 100 mL Solution for IV InfusionPP Infusion Bottle with Ring-Pull Type Cap x 50 mL, 100 mL, 250 mL, 500 mL, 1000 mL Not Applicable | Rx | Sichuan Kelun Pharmaceutical Co., Ltd.China | Sahar International Trading, Inc.Importer: Nueva Sunshine Phils., Inc. | DR-XY38495 | Sep 9, 2030 | |
Unbranded0.9% Sodium Chloride | 900 mg per 100 mL Solution for I.V. InfusionPolypropylene Plastic Bottle of 500mL and 1L - | Rx | Shanxi Nuocheng Pharmaceutical Co., Ltd.China | Endure Medical Inc. | DR-XY36133 | Jul 8, 2029 | |
UnbrandedSodium Chloride | 9mg/mL (0.9%) Solution for Intravenous Infusion100 mL, 500 mL, 1L LDPE Bottle | Rx | Ahlcon Parenteral (I) Ltd.India | Importer: B Braun Avitum Phils. Inc. | DR-XY45361 | Oct 23, 2028 | |
Unbranded0.9% Sodium Chloride | Solution for Intravenous InfusionPolyethylene Plastic Bottle x 1 Liter | Rx | AMHERST PARENTERALS, INC.Philippines | Trader: RITEMED PHILS., INC. | DR-XY14672 | Apr 12, 2029 | |
Visoline0.9% Sodium Chloride | 9 mg/mL (0.9% w/v) Solution for IV InfusionLDPE infusion bag x 1000 mL | Rx | Vision PharmaceuticalsPakistan | Surestep Pharmaceuticals, Inc. | DR-XY48987 | Jan 25, 2029 | |
WesoclearSodium Chloride | 6.5 mg/mL Nasal SprayWhite HDPE Nasal Spray Bottle x 30 mL (Box of 1’s) | OTC | LifeSquare Laboratories, Inc.Philippines | Westpoint Pharma Inc. | DRP-8484-03 | Oct 17, 2029 | |
Zen-NSS0.9% Sodium Chloride | 900 mg/100 mL (0.9% w/v) Solution for Intravenous InfusionLDPE Bottle x 1 L with white dust cap (Bottle of 1) | Rx | Shijiazhuang No. 4 Pharmaceutical Co., Ltd.China | Zenaust Pharma Inc.Importer: AGlobal Care, Inc. | DRP-14798-05 | Jan 9, 2029 | |
(no brand name)Sodium Chloride | 0.9% Solution For Injection (IV/SC)10 mL Plastic Ampoule "Mini-Plasco Connect" x 4's Box of 20's 20 mL Plastic Ampoule "Mini-Plasco Connect" x 4's Box of 20's | Rx | B. Braun Medical Industries Sdn. BhdMalaysia | B. Braun Medical Supplies, Incorporated | DR-XY13373 | Dec 6, 2027 | |
(no brand name)0.9% Sodium Chloride | 9 mg/mL (0.9% w/v) Solution for Injection | Rx | Euro-Med Laboratories Phil., Inc.Philippines | — | DR-XY49635 | Feb 11, 2031 | |
(no brand name)0.9% Sodium Chloride | 9 mg/mL (0.9% w/v) Solution for Injection (IV Infusion)PP Infusion Plastic Bottle Sealed with PP Cap x 50 mL | Rx | Shijiazhuang No. 4 Pharmaceutical Co., Ltd.China | Global Pharmatrade | DR-XY49032 | Apr 2, 2029 | |
(no brand name)0.9% Sodium Chloride | 9 mg/mL (0.9% w/v) Solution for Injection (IV Infusion)PP Infusion Plastic Bottle Sealed with PP Composite. Cap x 100 mL | Rx | Shijiazhuang No. 4 Pharmaceutical Co., Ltd.China | Global Pharmatrade | DR-XY49033 | Apr 2, 2029 | |
(no brand name)0.9% Sodium Chloride | 9 mg/mL (0.9% w/v) Solution for IrrigationPolypropylene bag x 3 L | Rx | Hebei Tiancheng Pharmaceutical Co., Ltd.China | AMB HK Enterprises Inc. | DRP-16062 | Oct 29, 2029 | |
(no brand name)0.9% Sodium Chloride | 900 mg/100 mL (0.9% w/v) Solution for IV InfusionFreeflex Polyolefin Bag x 100 m | Rx | Fresenius Kabi India Pvt. Ltd.India | Fresenius Kabi Philippines, Inc. | DR-XY48718 | May 4, 2028 | |
(no brand name)0.9% Sodium Chloride | 900 mg/100 mL (0.9% w/v) Solution for IV InfusionLDPE Plastic bottle x 100 mL, 500 mL and 1 L | Rx | Aculife Healthcare Private LimitedIndia | Blue Global (FZE) | DRP-15142 | May 13, 2029 | |
(no brand name)0.9% Sodium Chloride | 900mg/ 100mL Solution For IV InfusionPolyethylene Plastic Bottle x 50mL, 100mL, 500mL, 1000mL and 2000mL | Rx | General Hospital Products Public Co. Ltd.Thailand | Philsea Pharmaceuticals Products | DR-XY41260 | Dec 12, 2026 | |
(no brand name)0.9% Sodium Chloride | 9mg/mL (0.9% w/v) Soluition for Injection (IV Infusion)Clear Colorless PPE Bottle x 100mL, 500mL and 1L (Box of 30's) | Rx | PT. Satoria Aneka IndustriIndonesia | Deel Corporation | DR-XY49838 | Nov 10, 2031 |
Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.
Warnings/Precautions
Warnings and precautions (US label) US FDA label
WARNINGS Sodium Chloride Injection, USP should be used with great care, if at all, in patients with congestive heart failure, severe renal insufficiency and in clinical states in which there exists edema with sodium retention. The intravenous administration of Sodium Chloride Injection, USP can cause fluid and/or solute overloading resulting in dilution of serum electrolyte concentrations, overhydration, congested states or pulmonary edema.
The risk of dilutive states is inversely proportional to the electrolyte concentration of the injections. The risk of solute overload causing congested states with peripheral and pulmonary edema is directly proportional to the electrolyte concentrations of the injections. In patients with diminished renal function, administration of Sodium Chloride Injection, USP may result in sodium retention.
Drug interactions
Drug interactions (US label) US FDA label
DRUG INTERACTIONS Caution must be exercised in the administration of Sodium Chloride Injection, USP to patients receiving corticosteroids or corticotropin. Carcinogenesis, Mutagenesis, Impairment of Fertility Studies have not been performed with Sodium Chloride Injection, USP to evaluate the potential for carcinogenesis, mutagenesis or impairment of fertility.
Pregnancy: Teratogenic Effects Pregnancy Category C Animal reproduction studies have not been conducted with Sodium Chloride Injection, USP. It is also not known whether Sodium Chloride Injection, USP can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Sodium Chloride Injection, USP should be given to a pregnant woman only if clearly needed.
Labor and Delivery Studies have not been conducted to evaluate the effects of Sodium Chloride Injection, USP on labor and delivery. Caution should be exercised when administering this drug during labor and delivery. Nursing Mothers It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when Sodium Chloride Injection, USP is administered to a nursing mother.
Pediatric Use The use of Sodium Chloride Injection, USP in pediatric patients is based on clinical practice. Plasma electrolyte concentrations should be closely monitored in the pediatric population as this population may have impaired ability to regulate fluids and electrolytes. The infusion of hypotonic fluids (0.45% Sodium Chloride Injection, USP) together with the non-osmotic secretion of ADH may result in hyponatremia in patients with acute volume depletion.
Hyponatremia can lead to headache, nausea, seizures, lethargy, coma, cerebral edema and death, therefore acute symptomatic hyponatremic encephalopathy is considered a medical emergency. Geriatric Use Clinical studies of Sodium Chloride Injection, USP did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects.
Other reported clinical experience has not identified differences in responses between elderly and younger patients. In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or drug therapy.
This drug is known to be substantially excreted by the kidney, and the risk of toxic reactions to this drug may be greater in patients with impaired renal function. Because elderly patients are more likely to have decreased renal function, care should be taken in dose selection, and it may be useful to monitor renal function.
Do not administer unless solution is clear and container is undamaged. Discard unused portion.
Adverse reactions
Adverse reactions (US label) US FDA label
ADVERSE REACTIONS Reactions which may occur because of the solution or the technique of administration include febrile response, infection at the site of injection, venous thrombosis or phlebitis extending from the site of injection, extravasation and hypervolemia. If an adverse reaction does occur, discontinue the infusion, evaluate the patient, institute appropriate therapeutic countermeasures and save the remainder of the fluid for examination if deemed necessary.
In addition to the above listed adverse reactions hyponatremia has been reported for 0.45% Sodium Chloride Injection, USP (see PEDIATRIC USE section).
Pharmacokinetics
The distribution and excretion of sodium (Na+) and chloride (Cl−) are largely under the control of the kidney which maintains a balance between intake and output.
Pharmacokinetics (US label) US FDA label
CLINICAL PHARMACOLOGY When administered intravenously, these solutions provide a source of water and electrolytes. Solutions which provide combinations of hypotonic or isotonic concentrations of sodium chloride are suitable for parenteral maintenance or replacement of water and electrolyte requirements. Isotonic concentrations of sodium chloride are suitable for parenteral replacement of chloride losses that exceed or equal the sodium loss.
Hypotonic concentrations of sodium chloride are suited for parenteral maintenance of water requirements when only small quantities of salt are desired. A hypertonic concentration of sodium chloride may be used to repair severe salt depletion syndrome. Sodium chloride in water dissociates to provide sodium (Na+) and chloride (Cl−) ions.
Sodium (Na+) is the principal cation of the extracellular fluid and plays a large part in the therapy of fluid and electrolyte disturbances. Chloride (Cl−) has an integral role in buffering action when oxygen and carbon dioxide exchange occurs in the red blood cells. The distribution and excretion of sodium (Na+) and chloride (Cl−) are largely under the control of the kidney which maintains a balance between intake and output.
Water is an essential constituent of all body tissues and accounts for approximately 70% of total body weight. Average normal adult daily requirements range from two to three liters (1.0 to 1.5 liters each for insensible water loss by perspiration and urine production). Water balance is maintained by various regulatory mechanisms.
Water distribution depends primarily on the concentration of electrolytes in the body compartments and sodium (Na+) plays a major role in maintaining physiologic equilibrium.
Formulary and pricing (Philippines)
Government price references
| Preparation | Price (PHP) | Unit | Type |
|---|---|---|---|
| I.V. Fluids, 0.9% Sodium Chloride 1 L Bottle | ₱18.00–₱100.00Reference ₱26.60 | per bottle | DPRI procurement range |
| I.V. Fluids, 0.9% Sodium Chloride 1 L Soln for irrigation Bottle | ₱22.23–₱65.45Reference ₱32.89 | per bottle | DPRI procurement range |
| I.V. Fluids, 0.9% Sodium Chloride 100 mL Bag | ₱49.00–₱55.00Reference ₱49.00 | per bag | DPRI procurement range |
| I.V. Fluids, 0.9% Sodium Chloride 20 mL Ampule | ₱20.00–₱25.00Reference ₱20.00 | per ampule | DPRI procurement range |
| I.V. Fluids, 0.9% Sodium Chloride 50 mL Bottle | ₱16.24–₱46.00Reference ₱21.11 | per bottle | DPRI procurement range |
| I.V. Fluids, 0.9% Sodium Chloride 500 mL Bottle | ₱19.89–₱90.00Reference ₱28.89 | per bottle | DPRI procurement range |
| Sodium Chloride 2.5 mEq/mL, 20 mL Vial | ₱19.00–₱52.36Reference ₱19.00 | per vial | DPRI procurement range |
| Sodium Chloride 2.5 mEq/mL, 50 mL Vial | ₱21.34–₱49.50Reference ₱21.34 | per vial | DPRI procurement range |
Range = lowest-highest procurement price (highest usable only in GIDA areas); reference_price = 2021 DPRI ceiling (median)
These are government procurement and reimbursement references, not retail prices. Sources:
- DOH Drug Price Reference Index (DPRI) 2021, 9th edition (as of September 17, 2021); https://caro.doh.gov.ph/wp-content/uploads/2021/09/2021DPRI-as-of-9-17-2021.pdf, as of September 17, 2021
Formulary and coverage
| Philippine National Formulary | Listed as Sodium Chloride; 0.9% Sodium Chloride |
| PNF listing | Inj.: 2.5 mEq/mL, 20 mL and 50 mL vial |
| PNF listing | Inj.: 2 mL, 2.5 mL, 5 mL, 10 mL and 20 mL ampul |
| PNF listing | Inj.: 50 mL, 100 mL, 200 mL, 500 mL and 1 L bottle/bag (IV infusion) |
| PNF listing | Solution: 1 L bottle solution for irrigation |
| PNF listing | Composition: Na+ — 154 mmol/L Cl- — 154 mmol/L |
| PhilHealth GAMOT | No |
Sources:
- PNF Essential Medicines List, 8th ed. (as of November 2, 2022), DOH; https://www.philhealth.gov.ph/partners/providers/pdf/PNF-EML_11022022.pdf, as of November 2, 2022
Check availability
Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.
References
- U.S. Food and Drug Administration. SODIUM CHLORIDE · HF Acquisition Co LLC, DBA HealthFirst [US FDA-approved label, version 1, August 4, 2020]. Via DailyMed/openFDA. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ac0fd44a-3f39-8d7e-e053-2995a90afeec
- Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
- PNF Essential Medicines List, 8th ed. (as of November 2, 2022), DOH; https://www.philhealth.gov.ph/partners/providers/pdf/PNF-EML_11022022.pdf
- DOH Drug Price Reference Index (DPRI) 2021, 9th edition (as of September 17, 2021); https://caro.doh.gov.ph/wp-content/uploads/2021/09/2021DPRI-as-of-9-17-2021.pdf
This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.
Last updated: .


